Sign In
Buy MDT
$85.39
-0.320 (-0.373%)
At Close: Jul 31, 2026
I'm Buying 2 Must-Own Dividend Bargains
08:01am, Saturday, 31'st May 2025
The market continues to chase growth while ignoring once beloved income stocks. Verizon offers a compelling 6.3% dividend yield, robust free cash flow, and trades well below its historical valuation,
Does This Move Make Medtronic Stock a Buy?
07:45am, Saturday, 31'st May 2025
Over the past few years, Medtronic (MDT 0.80%) has faced significant challenges, including a pandemic-induced slowdown, relatively slow revenue growth, and economic issues that impacted its financial
Medtronic plc (MDT) Bernstein's 41st Strategic Decisions Conference - (Transcript)
09:13pm, Thursday, 29'th May 2025
Medtronic plc (NYSE:MDT ) Bernstein's 41st Strategic Decisions Conference Call May 29, 2025 11:00 AM ET Company Participants Geoff Martha - Chairman and Chief Executive Officer Thierry Pieton - Execut
ISRG vs. MDT: Which Robotic Surgery Stock Is a Smarter Buy Now?
10:25am, Thursday, 29'th May 2025
Intuitive Surgical or Medtronic -- who leads the future of robotic surgery? Here's a comparative analysis to help you make a smart choice for 2025.
We compared 5 Dividend Aristocrats, this one came out on top
07:11am, Tuesday, 27'th May 2025
A quarter of a century of increasing dividends is a hell of a way to generate some passive income. Enter Dividend Aristocrats.
No Rolex For Me - I'm Buying Dividends That Pay For Life
07:30am, Monday, 26'th May 2025
I love luxury watches, but buying more to "earn" access to rarer models made me realize how easy it is to waste capital chasing ego-driven goals. Unlike watches, dividend growth stocks offer reliable
Medtronic: Diabetes Spin-Off Is Near-Term Catalyst; Rating Upgrade
11:24pm, Sunday, 25'th May 2025
Upgrading Medtronic to 'Strong Buy' with a $104 fair value, driven by the diabetes business spin-off catalyst. Divesting diabetes enables Medtronic to focus on core cardiac and surgical markets, impro
Medtronic chairman and CEO Geoff Martha to speak at Bernstein's Strategic Decisions Conference
04:59pm, Friday, 23'rd May 2025
GALWAY, Ireland , May 23, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it will participate in Bernstein's 41st Strategic Decisions Confere
This Healthy High-Yielding Dividend Stock Just Increased Its Payment for the 48th Year in a Row
05:50am, Friday, 23'rd May 2025
Medtronic (MDT -4.12%) has been a dividend stalwart for decades. The medical device maker recently raised its dividend payment, extending its growth streak to 48 straight years.
Abbott vs. Medtronic: Which Dividend-Paying MedTech Stock is Better?
04:01pm, Thursday, 22'nd May 2025
With both MDT & ABT focusing on their core strengths, the stage is set for a compelling comparison. Let's see which stock is poised for greater upside.
'WIN-WIN': Medtronic CEO explains the reason for diabetes biz spin
02:00am, Thursday, 22'nd May 2025
Medtronic chairman and CEO Geoff Martha explains why the company is separating the diabetes business on 'The Claman Countdown.' #foxbusiness #usnews #economy #investing #diabetes #health #markets
Medtronic plc (MDT) Q4 2025 Earnings Call Transcript
01:08pm, Wednesday, 21'st May 2025
Medtronic plc (NYSE:MDT ) Q4 2025 Earnings Conference Call May 21, 2025 8:00 AM ET Company Participants Ryan Weispfenning - VP and Head of IR Geoff Martha - Chairman and CEO Que Dallara - EVP & Presid
Medtronic CEO: More companies are spinning off problems, we're spinning off an attractive asset
12:11pm, Wednesday, 21'st May 2025
Geoff Martha, Medtronic CEO, joins 'Money Movers' to discuss the company's spinoff plans, growth strategy and surgical robotics.
Compared to Estimates, Medtronic (MDT) Q4 Earnings: A Look at Key Metrics
10:31am, Wednesday, 21'st May 2025
Although the revenue and EPS for Medtronic (MDT) give a sense of how its business performed in the quarter ended April 2025, it might be worth considering how some key metrics compare with Wall Street
Medtronic to split off its fast-growing diabetes business to unlock its value
10:00am, Wednesday, 21'st May 2025
The new diabetes company will be predominantly business-to-consumer, while Medtronic's model was more business-to-business.
